Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
News Focus
SLAM DRILLS MORE COPPER MINERALIZATION AT GOODWIN (click to learn more)
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum XORTX Therapeutics Inc XRTX


Primary Symbol: V.XRTX

Healthcare
XORTX Therapeutics Inc. is a Canada-based late-stage clinical pharmaceutical company. The Company develops therapies to treat progressive kidney disease modulated by aberrant purine and uric acid metabolism in orphan disease indications, such as autosomal dominant polycystic kidney disease (ADPKD), as well as type 2 diabetic nephropathy (T2DN) and fatty liver disease. It is working to advance... see more

TSXV:XRTX - Post Discussion

XORTX Therapeutics Inc > AGM speaks Dilution and Insider Options Grab at $2/50/shr
View:
Post by SpaceLabs on Dec 30, 2021 3:08pm

AGM speaks Dilution and Insider Options Grab at $2/50/shr

DDoff, CEO is helping himself and his cronies to VERY CHEAP XRX shares on NASDAQ !

Since Nasdaq Listing, on every NR, XRX has TANKED Ab42 from Strip Mall Financier, am I right?

Only a mere $13M on Nasdaq and the RoadRunners/Analysts are UNABLE to attract Wall Street Investors???
There is no Product by Dr. Xortx, Omicron is now spreading/killing in wave 4, RELEASE the Product Allen DDoff !
Comment by diamondlessnono on Dec 31, 2021 12:58pm
Relax my friend. 2022 will make us rich.
Comment by SpaceLabs on Dec 31, 2021 2:13pm
This above from a FIFTH grader?,,,,we all know the product needs to be deployed by Skimmy D'DOOF in 2022.
Comment by diamondlessnono on Dec 31, 2021 3:46pm
My friend u nnd help.
XORTX Therapeutics Inc
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >
Dealroom for high-potential pre-IPO opportunities